Políticas Médicas
Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.
Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.
Tabla de Políticas Médicas
| ID | Título | Revisión | Descripción | Acceso |
|---|---|---|---|---|
| 13.007.001 | Maxillofacial Prosthesis | Oct 2024 | These are specialized and extensive prosthesis services to replace the loss of a great part of the facial and... | Ver |
| 13.008.001 | Frenectomy | Oct 2023 | It is the surgical procedure of the extirpation, dissection or muscular liberation of the frenulum that... | Ver |
| 13.009.001 | Maxillary Obturators | Aug 2023 | Maxillary obturators are considered a maxillofacial prosthesis. maxillary prosthetic devices are generally... | Ver |
| 13.009.002 | Oral Surgical Splint, Impression And Preparation | Nov 2020 | The oral splints are molds manufactured by the oral and maxillofacial surgeon prior to surgery. these molds... | Ver |
| 13.009.003 | Orthognathic Surgery | Aug 2026 | Are procedures that include surgical manipulation of the maxilla and /or the mandible to restore the correct... | Ver |
| 13.009.004 | Temporomandibular Joint Disorder | Mar 2026 | Temporomandibular joint disorder (tmjd) refers to a group of disorders characterized by pain in the... | Ver |
| 13.010.001 | Orthodontic Services | Oct 2024 | The branch of dentistry that is responsible for the study, prevention, diagnosis and treatment of anomalies... | Ver |
| 7.001.168 | Surgical Left Atrial Appendage Occlusion Devices for Stroke Prevention in Atrial Fibrillation | Sep 2022 | Atrial fibrillation (af) is the most common type of cardiac arrhythmia. stroke associated with af is... | Ver |
| 99.001.001 | Gene Therapies for Duchenne Muscular Dystrophy | Apr 2026 | Duchenne muscular dystrophy (dmd) is an inherited disorder that results in progressive muscle weakness and... | Ver |
| 99.999.999 | List of Retired Policies | Jul 2026 | List of retired... | Ver |
| M3.001.001 | Therapeutic Radiopharmaceuticals for Prostate Cancer | Aug 2026 | ... | Ver |
| M3.001.002 | Radio 223 Injection (Xofigo) | May 2025 | Approximately 240,000 men in the united states are expected to be diagnosed with prostate cancer in 2016.... | Ver |
| M5.001.001 | Viscosupplementation Therapy For Knee | May 2026 | Viscosupplementation therapy is part of the therapy used in the treatment of osteoarthritis of the knee.... | Ver |
| M5.001.002 | Rituximab | May 2026 | Rituximab is a genetically engineered chimeric murine/human monoclonal igg1 kappa antibody directed against... | Ver |
| M5.001.003 | Trastuzumab – Trastuzumab Biologics | Aug 2026 | Trastuzumab is a monoclonal antibody, one of a group of drugs designed to attack specific cancer cells.... | Ver |
| M5.001.005 | Bevacizumab | Aug 2026 | Bevacizumab is a humanized monoclonal antibody directed against vascular endothelial growth factor a... | Ver |
| M5.001.006 | G-Csf Filgrastim | Aug 2026 | White blood cell growth factors, also known as granulocyte colony stimulating factors (g-csf), are... | Ver |
| M5.001.007 | Somatuline® Depot; Lanreotide | May 2026 | Somatuline® depot; lanreotide is used to treat people with acromegaly (condition in which the body... | Ver |
| M5.001.008 | Simponi ARIA® (golimumab) | May 2026 | Golimumab is in a class of drugs called biologics. golimumab is a treatment for adults with moderate to... | Ver |
| M5.001.009 | Stelara® (ustekinumab) | May 2026 | Stelara is a human igg1κ monoclonal antibody that binds with high affinity and specificity to the p40... | Ver |
